MImAbs is a French CRO with 12 years of innovation in antibody science and a strong partnership-driven mindset. As part of Janvier Group Biosciences, we leverage cutting-edge technologies and deep expertise to support drug-development programs from early antibody discovery to advanced engineering and comprehensive characterization.
#Antibodies #Discovery #Partnership
expertise
Our team is composed of scientists committed to advancing therapeutic innovation through deep expertise in antibody discovery, engineering, analytical sciences, and pharmacology. With this know-how, we help accelerate development, de-risk key decisions, and guide programs toward impactful therapies.
Key Products or Services
We provide advanced antibody discovery using single B-cell screening from multiple species with a function-first approach. We also accelerate ADC development through our ADC Library program enabling rapid lead identification, efficient payload comparison, and early functional validation.
Vous souhaitez en savoir plus?
Marie Hommel
BD Director
marie.hommel@mimabs.com
+ 33 (0)6 70 77 45 35
Member of
